Physician profile
Patrick Acevedo
NPI 1639132269
$16,092.13
in general payments reported to CMS, 2019-2025
83 companies · $2,106 in 2025
The $2,106 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,186 · 2020: $3,017 · 2021: $2,053 · 2022: $2,040 · 2023: $2,174 · 2024: $2,517 · 2025: $2,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,332 · Education: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,331.84 |
| Education | $463.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,738.19 | 2019-2025 | |
| Janssen Biotech, INC. | $1,303.27 | 2019-2025 | Erleada, Rybrevant, Akeega |
| Seagen INC. | $1,151.89 | 2019-2025 | Adcetris, Tukysa, Tivdak |
| Celgene Corporation | $811.75 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Pfizer INC. | $806.02 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $785.84 | 2019-2025 | Enhertu, Imfinzi, Calquence |
| E.R. Squibb & Sons, L.L.C. | $747.48 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Merck Sharp & Dohme LLC | $482.68 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| Lilly USA, LLC | $475.24 | 2019-2024 | Jaypirca, Retevmo, Verzenio |
| Astellas Pharma US INC | $458.85 | 2019-2025 | Vyloy, Padcev, Xospata |
| Incyte Corporation | $444.29 | 2019-2025 | Jakafi, Monjuvi |
| Amgen INC. | $441.14 | 2019-2023 | Blincyto, Kyprolis, Lumakras |
| Genentech USA, INC. | $430.79 | 2019-2025 | Venclexta, Polivy, Lunsumio |
| Eisai INC. | $416.23 | 2020-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $411.48 | 2019-2023 | Imbruvica, Epkinly |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $281.27 | 2020-2025 | Ojjaara, Jemperli |
| Foundation Medicine, INC. | $275.45 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $271.28 | 2019-2025 | |
| Gilead Sciences, INC. | $250.49 | 2021-2025 | Trodelvy |
| Jazz Pharmaceuticals INC. | $241.26 | 2019-2024 | |
| Daiichi Sankyo INC. | $235.60 | 2019-2025 | Enhertu, Vanflyta, Datroway |
| Abbvie INC. | $211.73 | 2019-2024 | Venclexta |
| Genzyme Corporation | $203.69 | 2019-2024 | |
| Pharmacosmos Therapeutics INC. | $190.30 | 2023-2025 | Monoferric |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.77 | 2019-2025 | Gilotrif |
| Regeneron Healthcare Solutions, INC. | $163.60 | 2020-2025 | Libtayo |
| Kite Pharma, INC. | $135.97 | 2020-2025 | Yescarta |
| Array Biopharma INC | $128.31 | 2019-2025 | Mektovi, Braftovi, Tukysa |
| Beigene USA, INC. | $122.28 | 2023-2024 | Brukinsa, Tevimbra |
| Octapharma USA, INC. | $114.03 | 2020-2024 | Octagam Immune Globulin (Human) |
| Clovis Oncology, INC. | $112.75 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $111.13 | 2021-2023 | Xpovio |
| Amag Pharmaceuticals, INC. | $110.91 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.49 | 2019-2024 | Fruzaqla, Alunbrig |
| Taiho Oncology, INC. | $80.27 | 2023-2025 | |
| Exelixis INC. | $75.44 | 2023-2024 | Cabometyx |
| Emd Serono, INC. | $75.34 | 2022-2025 | |
| Stemline Therapeutics INC. | $74.94 | 2023 | Elzonris, Orserdu |
| Beone Medicines USA, INC. | $68.62 | 2025 | Brukinsa |
| Dendreon Pharmaceuticals LLC | $66.50 | 2020-2025 | Provenge |
| Servier Pharmaceuticals LLC | $64.32 | 2021-2025 | |
| Pharmaessentia USA Corporation | $59.39 | 2022-2025 | Besremi |
| Heron Therapeutics, INC. | $54.75 | 2019-2022 | |
| Secura Bio, INC. | $52.50 | 2019-2022 | |
| Sobi, INC | $52.32 | 2024 | |
| Rigel Pharmaceuticals, INC. | $47.62 | 2019-2023 | Tavalisse, Rezlidhia |
| Agios Pharmaceuticals, INC. | $46.25 | 2019-2023 | Pyrukynd |
| Alexion Pharmaceuticals, INC. | $45.96 | 2019-2025 | Ultomiris |
| Tempus Ai, INC | $44.21 | 2024 | Xt Cdx |
| Aveo Pharmaceuticals, INC. | $40.68 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $40.22 | 2019 | |
| Aurobindo Pharma USA, INC. | $40.05 | 2019-2020 | |
| Puma Biotechnology, INC. | $38.51 | 2021-2023 | |
| Lexicon Pharmaceuticals, INC. | $37.88 | 2019 | |
| Springworks Therapeutics, INC. | $36.71 | 2025 | Ogsiveo |
| Novocure INC. | $35.63 | 2024-2025 | Optune Lua (Novottf-200t) |
| G1 Therapeutics, INC. | $34.70 | 2022-2023 | Cosela |
| Tg Therapeutics, INC. | $33.08 | 2021 | |
| Emmaus Medical, INC. | $32.13 | 2020-2023 | Endari |
| Morphosys, US INC. | $30.95 | 2021-2022 | |
| Immunocore Limited | $28.85 | 2025 | Kimmtrak |
| Medtronic, INC. | $27.72 | 2024 | Osteocool Rf Ablation System |
| Dova Pharmaceuticals | $26.56 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $25.49 | 2020 | |
| Mirati Therapeutics, INC. | $23.79 | 2024 | Krazati |
| Sumitomo Pharma America, INC. | $23.49 | 2024 | Orgovyx |
| Blueprint Medicines Corporation | $23.11 | 2024 | Ayvakit |
| Telix Pharmaceuticals | $22.93 | 2023 | Illuccix |
| Geron Corporation | $22.76 | 2025 | Rytelo |
| Tesaro, INC. | $22.28 | 2019 | |
| Deciphera Pharmaceuticals INC. | $21.66 | 2024 | Qinlock, Tgct |
| Ipsen Biopharmaceuticals, INC | $20.62 | 2024 | Somatuline Depot, Onivyde |
| Eusa Pharma (US) LLC | $20.10 | 2022 | |
| Adc Therapeutics America, INC. | $18.93 | 2025 | |
| Tersera Therapeutics LLC | $18.87 | 2023 | Zoladex |
| Smith+Nephew, INC. | $18.51 | 2019 | |
| Legend Biotech USA INC. | $15.09 | 2025 | Carvykti |
| Myriad Genetic Laboratories, INC. | $14.96 | 2021 | |
| Epizyme, INC. | $14.82 | 2020 | |
| Sirtex Medical INC | $13.34 | 2020 | |
| Tactile Systems Technology INC | $12.55 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.46 | 2020 | |
| Veracyte, INC. | $0.82 | 2020 |
Drugs and devices associated with these payments
Reblozyl $303Jaypirca $296Retevmo $272Verzenio $266Keytruda $226Adcetris $214Jakafi $212Enhertu $210Lenvima $200Monoferric $190Opdivo $189Kisqali $187Opdualag $184Brukinsa $166Xtandi $150Venclexta $146Talzenna $136Libtayo $133Tukysa $133Orgovyx $126Pluvicto $121Imfinzi $117Padcev $110Elrexfio $109Nubeqa $108Imbruvica $105Trodelvy $94.21Xofigo $93.04Braftovi $91.13Mektovi $91.13Sarclisa $89.29Tivdak $88.82Erleada $84.69Lynparza $82.77Ibrance $81.15Inqovi $80.27Lonsurf $80.27Monjuvi $80.06Zepzelca $79.80Calquence $75.74Cabometyx $75.44Inlyta $71.57Vyndaqel $66.55Bosulif $65.24Comirnaty $61.81Scemblix $55.51Stivarga $53.89Vitrakvi $53.89Lutathera $53.11Vonjo $52.32Pomalyst $49.69Ojjaara $47.95Besremi $46.78Elzonris $46.00Illuccix $45.86Fabhalta $44.55Xt Cdx $44.21Octagam Immune Globulin (Human) $42.91Epkinly $41.57Krazati $40.28Vyloy $38.71Rybrevant $38.60Provenge $37.64Polivy $37.37Ogsiveo $36.71Optune Lua (Novottf-200t) $35.63Promacta $32.20Vanflyta $31.59Fruzaqla $31.21Orserdu $28.94Kimmtrak $28.85Tibsovo $28.30Osteocool Rf Ablation System $27.72Akeega $26.14Alunbrig $25.02Tevimbra $25.01Datroway $24.14Darzalex $24.08Welireg $23.68Jemperli $23.27Fotivda $23.19Ayvakit $23.11Rytelo $22.76Lorbrena $22.23Tgct $21.66Qinlock $21.66Cosela $21.49Pyrukynd $20.98Augtyro $20.80Somatuline Depot $20.62Onivyde $20.62Paxlovid $19.69Xpovio $19.64Ultomiris $19.53Yescarta $19.47Zynlonta $18.93Rezlidhia $18.91Tavalisse $18.91Zoladex $18.87Gazyva $18.42
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Acevedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.